Events

November 9: Thirumala-Devi Kanneganti, PhD, St. Jude Children's Research Hospital. "Targeting innate immunity and PANoptosis for the treatment of inflammatory and infectious diseases"

October 26: Charles Dela Cruz, MD, PhD, Yale University. "Type I and Type III Interferons in COVID‐19"

October 11: Tony Wang, Office of Vaccines and Research, FDA. "Rational Design of a Live Attenuated SARS-CoV-2 Vaccine Candidate" 

September 28: Joel Wertheim, PhD, associate professor of Medicine, UC San Diego. “Current perspective of the origin of SARS-CoV-2” 

September 7: Amber Smith, PhD, associate professor of Pediatrics. "COVID‐19 virtual patient cohort suggests immune mechanisms driving disease outcomes" 

July 29: Marcus T. Cicerone, PhD, and Ronit Sharon-Frilling, PhD, Georgia Institute of Technology. "Viral Envelopment and Host Cell Membrane Remodeling Mechanisms Explored with Label-Free Coherent Raman Microscopy" 

April 20: Brandt D. Pence, PhD, assistant professor, College of Health Sciences, University of Memphis. "SARS-CoV-2 spike protein induced immunometabolic activation in monocytes which can be blocked by metformin" 

March 30: Colleen Jonsson, PhD, director of the RBL and ISHPS, and Amber Smith, PhD, associate professor of Pediatrics. "The Emergence and Importance of SARS-CoV-2 Variants of Concern" 

March 9: Heather Smallwood, assistant professor of Pediatrics. "Clinical, immunological, and virological characterization of COVID-19 in children and adults: updates from the CIViC-19 study"